Press "Enter" to skip to content

Efficacy of TAS-102 Continues to Hold Up in Metastatic CRC and Gastric Cancers – Targeted Oncology

admin 0

Efficacy of TAS-102 Continues to Hold Up in Metastatic CRC and Gastric Cancers  Targeted Oncology

Howard S. Hochester, MD, discusses findings from the pooled safety analysis of TAS-102 in previously treated patients with colorectal cancer and …

“colorectal cancer” – Google News

(Visited 8 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *